Orphan Drug for Intrahepatic Bile Duct Cancer
Discover how PLT012, an innovative anti-CD36 antibody, targets liver cancer's sneaky recruitment stations, starving tumours, dismantling defences, and empowering T-cells to attack.
World-First Pilot Study Explores New Cholangiocarcinoma Treatment
Join a world-first pilot study testing durvalumab and olaparib for advanced cholangiocarcinoma. Now recruiting at eight sites across Australia. Learn more.
Immunotherapy and Chemotherapy Combinations for Cholangiocarcinoma
FDA approves Keytruda combo for cholangiocarcinoma, expanding options alongside Durvalumab. Explore immunotherapy breakthroughs and chemo combinations.
The Luckiest Unlucky Guy – The Matt Reidy Story
Matt's story shines a light on overcoming cholangiocarcinoma, from diagnosis and treatment to becoming a beacon of hope in the cancer community.
Evaluating the New Cholangiocarcinoma Vaccine Trial: A Patient-Centric Analysis”
An in-depth analysis of a cholangiocarcinoma vaccine trial, designed to empower patients with balanced insights into this experimental treatment.
Graeme Holmes
My younger brother Graeme begins this very important yet incredibly difficult page within our foundation
Orphan Drug for Intrahepatic Bile Duct Cancer
Discover how PLT012, an innovative anti-CD36 antibody, targets liver cancer's sneaky recruitment stations, starving tumours, dismantling defences, and empowering T-cells to attack.
World-First Pilot Study Explores New Cholangiocarcinoma Treatment
Join a world-first pilot study testing durvalumab and olaparib for advanced cholangiocarcinoma. Now recruiting at eight sites across Australia. Learn more.
Immunotherapy and Chemotherapy Combinations for Cholangiocarcinoma
FDA approves Keytruda combo for cholangiocarcinoma, expanding options alongside Durvalumab. Explore immunotherapy breakthroughs and chemo combinations.
The Luckiest Unlucky Guy – The Matt Reidy Story
Matt's story shines a light on overcoming cholangiocarcinoma, from diagnosis and treatment to becoming a beacon of hope in the cancer community.
Evaluating the New Cholangiocarcinoma Vaccine Trial: A Patient-Centric Analysis”
An in-depth analysis of a cholangiocarcinoma vaccine trial, designed to empower patients with balanced insights into this experimental treatment.
Graeme Holmes
My younger brother Graeme begins this very important yet incredibly difficult page within our foundation
